Viewing Study NCT00585195


Ignite Creation Date: 2025-12-24 @ 1:21 PM
Ignite Modification Date: 2025-12-29 @ 4:56 AM
Study NCT ID: NCT00585195
Status: COMPLETED
Last Update Posted: 2023-02-08
First Post: 2007-12-29
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-04-19
Start Date Type: ACTUAL
Primary Completion Date: 2020-07-30
Primary Completion Date Type: ACTUAL
Completion Date: 2022-01-19
Completion Date Type: ACTUAL
First Submit Date: 2007-12-29
First Submit QC Date: None
Study First Post Date: 2008-01-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2021-07-30
Results First Submit QC Date: None
Results First Post Date: 2021-10-14
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-01-10
Last Update Post Date: 2023-02-08
Last Update Post Date Type: ACTUAL